The Gigantic Potential With BAT... I choose to lif
Post# of 721
(Total Views: 238)
Posted On: 10/01/2020 11:57:43 AM
The Gigantic Potential With BAT... I choose to lift this again, since it seems not have got so much attention (in media). To put it simple; Imagine MULTIPLE type of products... 11 million salespoints/stores etc... ALL Over the world.
Tenbagger stock over a night or a week is not impossible at all, do the math.
Lexaria Bioscience Announces R&D Agreement With British American Tobacco
ACCESSWIRE - Mon Aug 31, 3:02PM CDT
KELOWNA, BC / ACCESSWIRE / August 31, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CNSX:LXX.CN) (the "Company" or "Lexaria"
, a global innovator in drug delivery platforms, announces that it has entered a research and development ("R&D" framework agreement with British American Tobacco (Investments) Limited ("BAT" to investigate Lexaria's technology for potential use in nicotine products.
R&D work under the Agreement will be paid for by BAT.
"Lexaria is pleased to work with British American Tobacco on these research and development activities," said Chris Bunka, Chief Executive Officer of Lexaria, who is also responsible for the accuracy of this news release.
The Agreement does not contemplate development of oral nicotine consumer products in North America, given Lexaria's existing North American relationship with a leading United States-based tobacco company. The Agreement is expected to be completed within six months, though provisions exist to extend the Agreement if required.
About BAT
British American Tobacco is a leading, multi-category consumer goods business, established in 1902. BAT's purpose is to build A Better Tomorrow by reducing the health impact of its business through offering a greater choice of enjoyable and less risky products for its consumers. British American Tobacco is one of the largest tobacco companies in the world with products sold in over 11 million locations across more than 180 countries.
Tenbagger stock over a night or a week is not impossible at all, do the math.
Lexaria Bioscience Announces R&D Agreement With British American Tobacco
ACCESSWIRE - Mon Aug 31, 3:02PM CDT
KELOWNA, BC / ACCESSWIRE / August 31, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CNSX:LXX.CN) (the "Company" or "Lexaria"
, a global innovator in drug delivery platforms, announces that it has entered a research and development ("R&D" framework agreement with British American Tobacco (Investments) Limited ("BAT" to investigate Lexaria's technology for potential use in nicotine products. R&D work under the Agreement will be paid for by BAT.
"Lexaria is pleased to work with British American Tobacco on these research and development activities," said Chris Bunka, Chief Executive Officer of Lexaria, who is also responsible for the accuracy of this news release.
The Agreement does not contemplate development of oral nicotine consumer products in North America, given Lexaria's existing North American relationship with a leading United States-based tobacco company. The Agreement is expected to be completed within six months, though provisions exist to extend the Agreement if required.
About BAT
British American Tobacco is a leading, multi-category consumer goods business, established in 1902. BAT's purpose is to build A Better Tomorrow by reducing the health impact of its business through offering a greater choice of enjoyable and less risky products for its consumers. British American Tobacco is one of the largest tobacco companies in the world with products sold in over 11 million locations across more than 180 countries.
(1)
(0)Lexaria Bioscience Corp. (LXRPD) Stock Research Links
Robert